Animal models in influenza vaccine testing

References

• Hinshaw VS. Influenza in other species (seal, whale and mink). In: Textbook of Influenza. Nicholson KG, Webster RG, Hay AJ (Eds). Blackwell Science Ltd, Oxford, UK 163–167 (1998).
   Google Scholar
• Smith W, Andrewes CH, Laidlaw PP. A virus obtained from influenza patients. Lancetii, 66–68 (1933).
   Google Scholar
• Webster RG, Govorkova E. Influenza-continuing evolution and spread. N. Engl. J. Med.355, 2174–2177 (2006).
   PubMed Web of Science ®Google Scholar
• Van Reeth K. Avian and swine influenza viruses: our current understanding of the zoonotic risk. Vet. Res.38, 243–260 (2007).
   PubMed Web of Science ®Google Scholar
• Houff SA, Miller GL, Lovell CR et al. The Guillain–Barré syndrome and swine influenza vaccination. Trans. Amer. Neurol. Soc.102, 120–123 (1977).
   Google Scholar
• Van Reeth K, Nauwynck H, Pensaert M. Bronchoalveolar interpheron-α, tumor necrosis factor-α, interleukin-1, and inflammation during acute influenza in pigs: a possible model for humans? J. Infect. Dis.177, 1076–1079 (1998).
   PubMedGoogle Scholar
• Van Reeth K, Van Gucht S, Pensaert M. Correlations between lung proinflammatory cytokine levels, virus replication, and disease after swine influenza virus challenge of vaccination-immune pigs. Viral Immunol.15, 583–594 (2002).
   PubMed Web of Science ®Google Scholar
• Solorzano A, Webby RJ, Lager KM et al. Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs. J. Virol.79, 7535–7543 (2005).
   PubMed Web of Science ®Google Scholar
• Scholtissek C, Hinshaw VS, Olsen CW. Influenza in pigs and their role as the intermediate host. In: Textbook of Influenza. Nicholson KG, Webster RG, Hay AJ (Eds). Blackwell Science Ltd, Oxford, UK 137–145 (1998).
   Google Scholar
• Ito T, Couceiro JN, Kelm S et al. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J. Virol.72, 7367–7373 (1998).
   PubMed Web of Science ®Google Scholar
• Shinya K, Ebina M, Yanada S et al. Influenza virus receptors in the human airway. Nature440, 435–436 (2006).
   PubMed Web of Science ®Google Scholar
• Hirst GK. Studies on the mechanism of adaptation of influenza virus to mice. J. Exp. Med.86, 357–366 (1947).
   PubMed Web of Science ®Google Scholar
• Subbarao K, Luke C. H5N1 viruses and vaccines. PLoS Pathog.3, 40 (2007).
   PubMed Web of Science ®Google Scholar
• Maines TR, Lu XH, Erb SM et al. Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J. Virol.79(18), 11788–11800 (2005).
   PubMed Web of Science ®Google Scholar
• Sidwell RW, Smee DF. in vitro and in vivo assay systems for study of influenza virus inhibitors. Antiviral Res.48, 1–16 (2000).
   PubMed Web of Science ®Google Scholar
• van Riel D, Munster VJ, de Wit E et al. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am. J. Pathol.171, 1215–1223 (2008).
   Google Scholar
• Ward AC. Virulence of influenza A virus for mouse lung. Virus Genes14, 187–194 (1997).
   Google Scholar
• Sidwell RW. The mouse model of influenza virus infection: In: Handbook of Animal Models of Infection. Zak O (Ed.). Academic Press, CA, USA 981–987 (1999).
   Google Scholar
• Burleson GR, Burleson FG. Influenza virus host resistance model. Methods41(1), 31–37 (2007).
   PubMed Web of Science ®Google Scholar
• Van Reeth K. Cytokines in the pathogenesis of influenza. Vet. Microbiol.74(1–2), 109–116 (2000).
   PubMed Web of Science ®Google Scholar
• Schulman JL. The use of an animal model to study transmission of influenza virus infection. Am. J. Public Health Nations Health58, 2092–2096 (1968).
   PubMed Web of Science ®Google Scholar
• Tamura S, Tanimoto T, Kurata T. Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines. Jpn. J. Infect. Dis.58(4), 195–207 (2005).
   PubMed Web of Science ®Google Scholar
• Sidwell RW, Smee DF. Experimental disease models of influenza virus infections: recent developments. Drug Discov. Today Dis. Models1, 57–63 (2004).
   Google Scholar
• Minne A, Jaworska J, Gerhold K et al. Intranasal delivery of whole influenza vaccine prevents subsequent allergen-induced sensitization and airway hyper-reactivity in mice. Clin. Exp. Allergy37, 1250–1258 (2007).
   PubMed Web of Science ®Google Scholar
• Sharpe M, Lynch D, Topham S et al. Protection of mice from H5N1 influenza challenge by prophylactic DNA vaccination using particle mediated epidermal delivery. Vaccine25(34), 6392–6398 (2007).
   PubMed Web of Science ®Google Scholar
• Lebrec H, Burleson GR. Influenza virus host resistance models in mice and rats: utilization for immune function assessment and immunotoxicology. Toxicology91(2), 179–188 (1994).
   PubMed Web of Science ®Google Scholar
• Armerding D, Rossiter H, Ghazzouli I, Liehl E. Evaluation of live and inactivated influenza A virus vaccines in a mouse model. J. Infect. Dis.145(3), 320–330 (1982).
   Google Scholar
• Lu X, Renshaw M, Tumpey TM et al. Immunity to influenza A H9N2 viruses induced by infection and vaccination. J. Virology75(10), 4896–4901 (2001).
   Google Scholar
• Desheva JA, Lu XH, Rekstin AR et al. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential. Vaccine24, 6859–6866 (2006).
   PubMed Web of Science ®Google Scholar
• Ichinohe T, Tamura S, Kawaguchi A et al. Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine. J. Infect. Dis.196, 1313–1320 (2007).
   PubMed Web of Science ®Google Scholar
• Zanvit P, Havlícková M, Tácner J et al. Protective and cross-protective mucosal immunization of mice by influenza virus type A with bacterial adjuvant. Immunol. Lett.115, 144–152 (2008).
   Google Scholar
• Smith W, Andrewes CH, Laidlow PP. Influenza: experiments on the immunisation of ferrets and mice. Br. J. Exp. Pathol.16, 291–302 (1937).
   Google Scholar
• Smith W, Stuart-Harris CH. Influenza infection of man from the ferret. Lancet2, 121 (1936).
   Google Scholar
• Burnet FM, Clarke E. Influenza: a survey of the last 50 years in the light of modern work on the virus of epidemic influenza. Monographs Res. Med.4, 1–118 (1942).
   Google Scholar
• Andrewes CH, Glover RE. Spread of infection from the respiratory tract of the ferret. Transmission of influenza A virus. Br. J. Exp. Pathol.22, 91–97 (1941).
   Google Scholar
• Herlocher ML, Elias S, Truscan R et al. Ferrets as a transmission model for influenza: sequence changes in HA1 of type A (H3N2) virus. J. Inf. Dis.184, 542–526 (2001).
   PubMedGoogle Scholar
• Hers JF, Mulder J. Broad aspects of the pathology and pathogenesis of human influenza. Amer. Rev. Resp. Dis.83, 54 (1961).
   Google Scholar
• Smith W, Andrewes CH, Stuart-Harris CH. A study of epidemic influenza with special reference to the 1936–7 epidemic. studies on immunisation of ferrets and mice. Med. Res. Council (Brit.) Spec. Rep. Series228, 125–127 (1938).
   Google Scholar
• Stuart-Harris CH. Influenza and Other Virus Infections of the Respiratory Tract. Edward Arnold, London, UK 235 (1935).
   Google Scholar
• Rennie P, Bowtell P, Hull D et al. Low pH gel sprays inactivate influenza viruses in vitro and protect ferrets against influenza infection. Resp. Res.8, 38–45 (2007).
   PubMedGoogle Scholar
• Ives JA, Carr JA, Mendel DB et al. The H274Y mutation in the influenza A (H1N1) neuraminidase active site following oseltamivir phosphate treatment leaves virus severely compromised both in vitro and in vivo. Antiviral. Res.55, 307 (2002).
   PubMed Web of Science ®Google Scholar
• Smith H, Sweet C. Lessons for human influenza from pathogenicity studies with ferrets. Rev. Inf. Dis.10, 56–75 (1988).
   PubMedGoogle Scholar
• Zitzow LA, Rowe T, Morken T et al. Pathogenesis of avian influenza A (H5N1) viruses in ferrets. J. Virol.76, 4420–4429 (2002).
   PubMed Web of Science ®Google Scholar
• Ochi A, Danesh A, Seneviratne C et al. Cloning, expression and immunoassay detection of ferret IFN-γ. Dev. Comp. Immunol.32(8), 890–897 (2008).
   PubMedGoogle Scholar
• Stuart Harris CH, Andrewes CH, Smith W. A study of epidemic influenza with special reference to the 1936–37 epidemics. Med. Res. Council (Brit.) Special Report Series22 (1938).
   Google Scholar
• Baras B, Stittelaar KJ, Simon JH et al. Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine. PloS One3(1), e1401 (2008).
   PubMed Web of Science ®Google Scholar
• Reuman PD, Keely S, Schiff GM. Assessment of signs of influenza illness in the ferret model. J. Virol. Methods24, 27–34 (1989).
   PubMed Web of Science ®Google Scholar
• Lambkin-Williams R, Herog C, Viret JF et al. Strong local and systemic protective immunity inducing the ferret model by an intranasal virosome formulated influenza sub unit vaccine. Vaccine22, 4930–4996 (2004).
   Google Scholar
• Mann A, Marriott AC, Balasingam S et al. Interfering vaccine (defective interfering influenza A virus) protects ferrets from influenza and allows them to develop solid immunity. Vaccine24, 4290–4296 (2006).
   Google Scholar
• Fenton RJ, Clark A, Potter CW. Comparative immunity following infection and immunity with live or inactivated vaccine. Br. J. Exp. Path.62, 297–307 (1981).
   Google Scholar
• Govorkova EA, Rehg JE, Krauss S et al. Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004. J. Virol.79, 2191–2198 (2005).
   PubMed Web of Science ®Google Scholar
• Hampson AW. Ferrets and the challenges of H5N1 vaccine formulation. J. Infect. Dis.194, 143–145 (2006).
   PubMed Web of Science ®Google Scholar
• Hui Ling Yen, Lipatov AS, Ilyushina NA et al. Inefficient transmission of H5N1 influenza viruses in a ferret contact model. J. Virol.81(13), 6890–6898 (2007).
   Google Scholar
• Govorkova EA, Webby RJ, Humberd J et al. Immunization with reverse genetics produced H5N1 influenza vaccine protects ferrets against homologous and heterogous challenge. J. Infect. Dis.194, 159–167 (2006).
   PubMed Web of Science ®Google Scholar
• Lipatov AS, Hoffmann E, Salomon R et al. Cross-protectiveness and immunogenicity of influenza A/Duck/Singapore/3/97 (H5) vaccines against infection with A/Vietnam/1203/04 (H5N1) virus in ferrets. J. Infect. Dis.194, 1040–1043 (2006).
   PubMedGoogle Scholar
• Ferguson NM, Cummings, DA, Fraser C et al. Strategies for mitigating an influenza pandemic. Nature442, 448–452 (2006).
   PubMed Web of Science ®Google Scholar
• Germann TC, Kadau K, Longini IM Jr et al. Mitigation strategies for pandemic influenza in the United States. Proc. Natl Acad. Sci. USA103, 5935–5940 (2006).
   PubMed Web of Science ®Google Scholar
• Rimmelzwaan GF, Baars M, Van Beek R et al. Induction of protective immunity against influenza virus in a macaque model: comparison of conventional and iscom vaccines. J. Gen. Virol.78, 757–765 (1997).
   PubMed Web of Science ®Google Scholar
• Villinger F, Miller R, Mori K et al. IL-15 is superior to IL-2 in the generation of long-lived antigen specific memory CD4 and CD8 T cells in rhesus macaques. Vaccine22, 3510–3521 (2004).
   PubMed Web of Science ®Google Scholar
• Baskin CRA, Garcia-Sastre A, Tumpey TM et al. Integration of clinical data, pathology, and DNA microarrays in influenza virus-infected pigtailed macaques (Macaca nemestrina). J. Virol.78, 10420–10432 (2004).
   PubMed Web of Science ®Google Scholar
• Kobasa D, Jones SM, Shinya K et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature445, 319–323 (2007).
   PubMed Web of Science ®Google Scholar
• Rimmelzwaan GF, Kuiken T, Van Amerongen G et al. Pathogenesis of influenza A (H5N1) virus infection in a primate model. J. Virol.75(14), 6687–6691 (2001).
   PubMed Web of Science ®Google Scholar
• Hubby B, Talarico T, Maughan M et al. Development and preclinical evaluation of an avirus replicon vaccine for influenza. Vaccine25, 8180–8189 (2007).
   PubMed Web of Science ®Google Scholar
• Baas T, Baskin CR, Diamond DL et al. Integrated molecular signature of disease: analysis of influenza virus-infected macaques through functional genomics and proteomics. J. Virol.80(21), 10813–10828 (2006).
   PubMed Web of Science ®Google Scholar
• Ruat Caillet C, Bidaut et al. Vaccination of macaques with adjuvanted formalin-inactivated influenza A (H5N1) vaccines: protection against H5N1 challenge without disease enhancement. J. Virol.82, 2565–2569 (2008).
   Google Scholar
• Itoh Y, Ozaki H, Tsuchiya et al. A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques. Vaccine26, 562–572 (2008).
   PubMedGoogle Scholar
• Fornek JL, Korth MJ, Katze MG. Use of functional genomics to understand influenza–host interactions. Adv. Virus Res.70, 81–100 (2007).
   PubMedGoogle Scholar
• Lowen AC, Mubareka S, Tumpey TM et al. The guinea pigs as a transmission model for human influenza viruses. Proc. Natl Acad. Sci. USA103, 9988–9992 (2006).
   PubMed Web of Science ®Google Scholar
• Van Riel D, Munster VJ, De Wit E et al. H5N1 virus attachment to lower respiratory tract. Science312, 399 (2006).
   PubMed Web of Science ®Google Scholar
• Medical Research Committee. Special report series no. 36. Studies of influenza in hospitals of the British armies in France. HM Stationary Office, London, UK (1919).
   Google Scholar
• Report on the pandemic of influenza 1918–1919. Reports on the public health and medical subjects, no. 4. HM Stationary Office, London, UK (1920).
   Google Scholar